Nakano T, Terawaki A, Arita H
J Biochem. 1986 Apr;99(4):1285-8. doi: 10.1093/oxfordjournals.jbchem.a135594.
Using aequorin-loaded rat platelets stimulated with collagen, we found two phases of Ca2+ mobilization, one coinciding with a shape change and the other with aggregation, which have not yet been detected in quin2-loaded platelets. U46619, a stable analogue of prostaglandin H2, induced only a shape change and a concomitant rapid rise in the cytoplasmic ionized calcium concentration ([Cai2+]). However, upon addition of U46619 to platelets previously stimulated with collagen in the presence of indomethacin, a rapid increase in [Cai2+] and a shape change occurred, and, after about 1 min, second increase in [Cai2+] and aggregation occurred. The actions of U46619 were inhibited by an antagonist for the thromboxane A2 (TXA2) receptor. These results suggest that the collagen-induced shape change is initiated by TXA2-induced Ca2+ mobilization, and aggregation is induced by the secondary Ca2+ mobilization induced by TXA2 and the occupation of the receptor by collagen.
在用胶原蛋白刺激负载水母发光蛋白的大鼠血小板时,我们发现了两个钙离子动员阶段,一个与形状变化同时发生,另一个与聚集同时发生,而在负载喹啉-2的血小板中尚未检测到这两个阶段。前列腺素H2的稳定类似物U46619仅诱导形状变化以及细胞质游离钙浓度([Cai2+])随之迅速升高。然而,在吲哚美辛存在的情况下,将U46619添加到先前用胶原蛋白刺激过的血小板中时,[Cai2+]迅速增加并发生形状变化,并且在大约1分钟后,[Cai2+]再次增加并发生聚集。血栓素A2(TXA2)受体拮抗剂抑制了U46619的作用。这些结果表明,胶原蛋白诱导的形状变化由TXA2诱导的钙离子动员引发,而聚集则由TXA2诱导的继发性钙离子动员以及胶原蛋白对受体的占据所诱导。